McQuade CR et al. - The case of a patient who developed clinically relevant increases in serum creatinine (SCr) levels while receiving fenofibrate therapy is reported. It was concluded that patient developed renal impairment after receiving fenofibrate for the treatment of hypertriglyceridemia